Abstract:Background Defects in the alpha-synuclein, leucine-rich repeat kinase 2, or glucocerebrosidase genes have been regarded as essential contributors to PD. However, genetic variability of these genes with respect to early-onset PD remains poorly defined for the Chinese demographic. Objectives We aim to systematically characterize the clinical and genetic architecture of alpha-synuclein, leucine-rich repeat kinase 2, and glucocerebrosidase in Chinese early-onset PD patients. Methods Whole-exome sequencing and Sanger sequencing were used to identify variants of alpha-synuclein, leucine-rich repeat kinase 2, and glucocerebrosidase in 662 Chinese early-onset PD patients. Haplotype and burden analyses were conducted to investigate the role of rare variants of these three genes in early-onset PD. Results Sixty rare variants, including 23 novel variants, were identified in 73 patients (11.0%). Frequencies of patients with rare pathogenic/likely pathogenic variants of alpha-synuclein, leucine-rich repeat kinase 2, and glucocerebrosidase were 0.6%, 3.0%, and 5.4%, respectively. Evidences of two founder events exclusive to Asians were identified in 2 patients with leucine-rich repeat kinase 2 p.R1441C and 3 patients with alpha-synuclein p.A53V. Gene-based burden analysis supported glucocerebrosidase as a strong risk factor for early-onset PD, but argued against over-representation of rare variants in alpha-synuclein or leucine-rich repeat kinase 2 in early-onset PD. Clinically, no differences in motor or nonmotor symptoms were found between glucocerebrosidase variants carriers, and noncarriers or between leucine-rich repeat kinase 2 carriers and noncarriers. Patients with alpha-synuclein variants showed both rapid progression and worse cognitive impairment. Conclusion Our study provides a better understanding of the clinical and genetic correlations of alpha-synuclein, leucine-rich repeat kinase 2, and glucocerebrosidase in early-onset PD, which may be beneficial for drafting genetic scanning strategies and evaluating disease progression. (c) 2020 International Parkinson and Movement Disorder Society

Clinical Variability in Chinese Families with Parkinson Disease and SNCA Duplication, Including the Shortest 139kb Duplication

[Genetic and Clinical Analysis in a Parkinson's Disease Family Caused by Expansion of SCA2].

The role of NOTCH2NLC in Parkinson's disease: A clinical, neuroimaging, and pathological study

[Genetic Study of a Parkinson's Disease Pedigree Caused by Compound Heterozygous Mutations in PARK2 Gene].

Genetic Analysis and Literature Review of SNCA Variants in Parkinson's Disease

Analysis of Rare Variants of Autosomal‐dominant Genes in a Chinese Population with Sporadic Parkinson’s Disease

A Novel Homozygous SYNJ1 Mutation in Two Siblings with Typical Parkinson's Disease.

Evaluating the Role of SNCA, LRRK2, and GBA in Chinese Patients with Early‐Onset Parkinson's Disease

Genome-wide association study of copy number variations in Parkinson's disease

Genetic Variants In The Rab7l1 And Slc41a1 Genes Of The Park16 Locus In Chinese Parkinson'S Disease Patients

Genetic Analysis of SNCA Coding Mutation in Chinese Han Patients with Parkinson Disease

Association study between two novel single nucleotide polymorphisms and sporadic Parkinson's disease in Chinese Han population.

Snca Rs356219 Variant Increases Risk of Sporadic Parkinson'S Disease in Ethnic Chinese

The Genetic Spectrum of a Cohort of Patients Clinically Diagnosed As Parkinson's Disease in Mainland China.

No Association of FAM47E Rs6812193, SCARB2 Rs6825004 and STX1B Rs4889603 Polymorphisms with Parkinson's Disease in a Chinese Han Population.

High-depth Whole-Genome Sequencing Identifies Structure Variants, Copy Number Variants and Short Tandem Repeats Associated with Parkinson’s Disease

SNPs in SNCA, MCCC1, DLG2, GBF1 and MBNL2 Are Associated with Parkinson's Disease in Southern Chinese Population

Snp Rs7684318 of the Alpha-Synuclein Gene is Associated with Parkinson'S Disease in the Han Chinese Population

Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson’s Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population

Analysis of SCA2 and SCA3/MJD repeats in Parkinson's disease in mainland China genetic, clinical, and PET findings